Medtech company active since 2000 with patented 3D biofabrication technology - Central Switzerland

This Swiss medical technology company, active for more than twenty years, develops technical solutions for the healthcare sector. Its main asset is a cable robot platform, protected by an international patent, which meets the needs of 3D printing of biological material. The patented design is protected in many countries. It offers very precise positioning, down to a hundredth of a millimetre, while keeping a large freedom of movement in space. Its compact format, scalability and operational reliability set it apart. It is suited to the fabrication of cell structures, tissues and organ-like substrates, as well as to regenerative medicine laboratories and future industrial applications in bioengineering. Prototypes and operational systems already exist. The business model can evolve towards research, licensing or series production. The fixed cost structure is light, which makes a simple takeover or integration into an existing group easier. International partnerships and spin-offs are possible. This opportunity is aimed at strategic investors active in medtech or biotechnology, biofabrication research companies, technology companies looking for innovative niches, as well as university spin-offs or joint ventures between universities and clinics. Handover is possible immediately. Detailed documents are provided after signing a non-disclosure agreement.